Key Compliance Statement
The company confirms there are no deviation(s) or variation(s) in the utilization of proceeds raised through the Initial Public Offer (IPO) during the half year ended September 30, 2026.
Financial Details of IPO Proceeds
- Total Amount Raised: ₹4,200 lakhs
- Date of Allotment: January 29, 2026
- Monitoring Agency: Not Applicable
Fund Utilization Details as of September 30, 2026
Capital Expenditure for Establishing Radiation Oncology
- Amount Disclosed in Offer Document: ₹3,498.21 lakhs
- Actual Utilized Amount: ₹152.80 lakhs
- Unutilized Amount: ₹3,345.41 lakhs
- Deviation/Variation: Not Applicable
- Remarks: Nil
General Corporate Purposes
- Amount Disclosed in Offer Document: ₹32.15 lakhs
- Actual Utilized Amount: ₹32.15 lakhs
- Unutilized Amount: ₹0.00 lakhs
- Deviation/Variation: Not Applicable
- Remarks: Nil
Issue Related Expenses
- Amount Disclosed in Offer Document: ₹669.64 lakhs
- Actual Utilized Amount: ₹655.38 lakhs
- Unutilized Amount: ₹14.26 lakhs
- Deviation/Variation: Not Applicable
- Remarks: Nil
Total Utilization
- Total Amount Raised: ₹4,200 lakhs
- Total Actual Utilized: ₹840.33 lakhs
- Total Unutilized: ₹3,359.67 lakhs
Additional Financial Information
Fixed deposits interest (gross) for IPO Proceeds kept in Kotak Mahindra Bank: ₹31.50 lakh (₹3,149,578) not included in the unutilized amount.
Governance and Approval Process
- The Statement of Deviation or Variation was reviewed by the Audit Committee
- The statement was taken on record by the Board of Directors
- Both meetings were held on November 5, 2026
External Certification
Chartered Accountants A.V. Subramanian & Co certified the utilization of IPO proceeds through a certificate dated November 4, 2026 (UDIN: 26223529PCUQPL2095). The certification was signed by CA.A. Padma, M.Com., FCA., Membership No. 223529, Partner of the firm (ICAI FRN: 010643S).